Use of D-dimer assays in the diagnosis of venous thrombosis

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 6, 2000, Pages 631-641

  Dempfle, C E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Assay systems; D dimer; Outpatient diagnosis; Pulmonary embolism; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 13A; D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRIN DERIVATIVE; FIBRINOGEN;

BLOOD CLOTTING; COVALENT BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRIN FORMATION; FIBRIN POLYMERIZATION; LUNG EMBOLISM; OUTPATIENT CARE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STANDARDIZATION; VALIDATION PROCESS; VEIN THROMBOSIS;

ANTIFIBRINOLYTIC AGENTS; CLINICAL TRIALS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MASS SCREENING; PULMONARY EMBOLISM; REAGENT KITS, DIAGNOSTIC; VENOUS THROMBOSIS;

EID: 0034532266     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13221     Document Type: Review

References (67)

1. The products of the action of thrombin on fibrinogen
2. Evidence for four different polymerization sites involved in human fibrin formation
3. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII
4. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin
5. The lysis of cross-linked human fibrin by plasmin yields initially a single molecular complex, D-Dimer-E
6. An immunoassay for human D dimer using monoclonal antibodies
7. Measurement of cross-linked fibrin degradation products - An immunoassay using monoclonal antibodies
8. Measurement of cross linked fibrin derivatives in plasma: An immunoassay using monoclonal antibodies
9. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis
10. Fibrin degradation product (FnDP) assays: Analysis of standardization issues and target antigens in plasma
11. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A
12. Identification of D-dimer-E complex in disseminated intravascular coagulation
13. An integrated study of fibrinogen during blood coagulation
14. D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: Diagnostic value in clinically suspected deep vein thrombosis
15. Non-invasive diagnosis of venous thromboembolism in outpatients
16. Clinical evaluation of a diagnostic strategy for deep venous thrombosis with exclusion by low plasma levels of fibrin degradation product D-dimer
17. D-rimer testing for suspected pulmonary embolism in outpatients
18. Tumor shedding and coagulation
19. Fibrinogen and fibrin derivatives in traumatized patients: Relation to injury severity and posttraumatic pulmonary dysfunction
20. Application of a bedside whole blood D-dimer assay in the diagnosis of deep vein thrombosis
21. Application of a diagnostic clinical model for the management of hospitalized patients with suspected deep-vein thrombosis
22. Assay of D-dimer based on immunofiltration and staining with gold colloids
23. A new, semi-quantitative and individual ELISA for rapid measurement of plasma D-dimer in patients suspected of pulmonary embolism
24. A new sensitive membrane based ELISA technique for instantaneous D-dimer evaluation in emergency
25. The detection of D-dimer in plasma by enzyme immunoassay: Improved discrimination is obtained with a more specific signal antibody
26. Reactivity of D-dimer assays with the fibrinogen - Fibrin split products generated by thrombolytic agents
27. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody
28. VIDAS D-dimer: Fast quantitative ELISA for measuring D-dimer in plasma
29. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay
30. Multizentrische evaluierung von tina-quant a D-dimer
31. Nephelometric determination of plasma D-dimer
32. Comparison of new automated latex assays for D-dimer with ELISAs for the exclusion of deep venous thrombosis
33. Exclusion of deep venous thrombosis with D-dimer testing. Comparison of 13 D-dimer methods in 99 outpatients suspected of venous thrombosis using venography as reference standard
34. Diagnostic value of compression ultrasonography and fibrinogen-related parameters for the detection of postoperative deep vein thrombosis following elective hip replacement: A pilot study
35. Deep vein thrombosis in stroke. The use of plasma D-dimer level as a screening test in the rehabilitation setting
36. Comparison of three D-dimer assays for the diagnosis of DVT:ELISA, latex and an immunofiltration assay (NycoCard D-Dimer)
37. Assessment of D-dimer in plasma: Diagnostic value in suspected deep venous thrombosis of the leg
38. Measurement of plasma D-dimer for diagnosis of deep venous thrombosis
39. Comparison of various D-dimer tests for the diagnosis of deep venous thrombosis
40. Comparison of the appropriateness of the latex and ELISA plasma D-dimer determination for the diagnosis of deep venous thrombosis
41. D-dimer test and diagnosis of deep vein thrombosis: A comparative study of 7 assays
42. D-dimer strategy in thrombosis exclusion. A gold standard study in 100 patients suspected of venous thrombosis or pulmonary embolism: 8 DD methods compared
43. D-dimer determination to assess regression of deep venous thrombosis
44. Investigations into the clinical utility of latex D-dimer in the diagnosis of deep venous thrombosis
45. Comparison of new rapid methods for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients
46. Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients
47. Whole-blood immunoassay (SimpliRED) versus plasma immunoassay (NycoCard) for the diagnosis of clinically suspected deep vein thrombosis
48. A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis
49. Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis
50. Comparison of immunofiltration assay of plasma D-dimer with diagnostic imaging in deep vein thrombosis
51. DVT exclusion in symptomatic outpatients: Use of a rapid D-dimer immunofiltration assay and comparison with three enzyme immuno assays
52. Diagnostic value of a new sensitive membrane based technique for instantaneous D-dimer evaluation in patients with clinically suspected deep venous thrombosis
53. Assessment of D-dimer assays for the diagnosis of deep vein thrombosis
54. Measurement of crosslinked fibrin derivatives - Use in the diagnosis of venous thrombosis
55. The use of D-dimer assay by enzyme immunoassay and latex agglutination techniques in the diagnosis of deep vein thrombosis
56. Contribution of a new, rapid, quantitative and automated method for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients
57. The use of the D-dimer test in combination with non-invasive testing versus serial non-invasive testing alone for the diagnosis of deep-vein thrombosis
58. Rapid quantitative D-dimer assay and clinical evaluation for the diagnosis of clinically suspected deep vein thrombosis
59. The value of D-dimer assays in the emergency diagnosis of venous thrombosis
60. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
61. Evaluation of a new rapid quantitative D-dimer assay in patients with clinically suspected deep vein thrombosis
62. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism
63. Value of liquid crystal contact thermography and plasma level of D-dimer for screening of deep venous thrombosis following general abdominal surgery
64. Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty
65. Clinical utility of prothrombin fragment F1+2, thrombin antithrombin III complexes, and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement
66. Plasma D-dimer as a marker for postoperative deep venous thrombosis. A study after total hip or knee arthroplasty
67. The clinical utility of a rapid bedside D-dimer assay for screening of deep venous thrombosis following orthopedic surgery